CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Total revenues	$ 24,244	$ 28,859	$ 80,011	$ 77,019
Cost of revenues:
Total cost of revenues	18,445	25,112	63,450	68,691
Gross profit	5,799	3,747	16,561	8,328
Operating expenses:
Selling, general and administrative	6,860	5,201	20,515	15,839
Amortization of intangible assets	430	430	1,290	1,298
Gain on sale of MD Office Solutions	0	0	0	(847)
Total operating expenses	7,290	5,631	21,805	16,290
Income (loss) from operations	(1,491)	(1,884)	(5,244)	(7,962)
Other income (expense):
Other income (expense), net	(575)	3	(997)	4,208
Interest expense, net	(185)	(260)	(664)	(732)
Total other income (expense)	(760)	(257)	(1,661)	3,476
Income (loss) from continuing operations before income taxes	(2,251)	(2,141)	(6,905)	(4,486)
Income tax benefit (provision)	367	0	(256)	(34)
Income (loss) from continuing operations, net of tax	(1,884)	(2,141)	(7,161)	(4,520)
Income (loss) from discontinued operations, net of tax	0	0	0	5,955
Net income (loss)	(1,884)	(2,141)	(7,161)	1,435
Deemed dividend on Series A perpetual preferred stock	(479)	(479)	(1,437)	(1,437)
Net income (loss) attributable to common shareholders	(2,363)	(2,620)	(8,598)	(2)
Net income (loss) attributable to common shareholders	$ (2,363)	$ (2,620)	$ (8,598)	$ (2)
Net income (loss) per share—basic and diluted
Net income (loss) per share, continuing operations, basic (in usd per share)	$ (0.12)	$ (0.42)	$ (0.49)	$ (0.90)
Net income (loss) per share, continuing operations, diluted (in usd per share)	(0.12)	(0.42)	(0.49)	(0.90)
Net income (loss) per share, discontinued operations, basic (in usd per share)	0	0	0	1.19
Net income (loss) per share, discontinued operations, diluted (in usd per share)	0	0	0	1.19
Net income (loss) per share - basic (in usd per share)	(0.12)	(0.42)	(0.49)	0.29
Net income (loss) per share - diluted (in usd per share)	(0.12)	(0.42)	(0.49)	0.29
Deemed dividend on Series A cumulative perpetual preferred stock per share (in usd per share)	(0.03)	(0.09)	(0.10)	(0.29)
Net income (loss) per share, attributable to common shareholders— basic (in usd per share)	(0.15)	(0.51)	(0.59)	0
Net income (loss) per share, attributable to common shareholders— diluted (in usd per share)	$ (0.15)	$ (0.51)	$ (0.59)	$ 0
Weighted-average shares outstanding - basic (in shares)	15,434	5,101	14,503	5,019
Weighted-average shares outstanding - diluted (in shares)	15,434	5,101	14,503	5,019
Dividends declared per Series A perpetual preferred stock (in usd per share)	$ 0.25	$ 0.25	$ 0.75	$ 0.50
Healthcare
Revenues:
Total revenues	$ 13,137	$ 14,807	$ 40,467	$ 42,984
Cost of revenues:
Total cost of revenues	10,412	11,551	30,888	33,721
Construction
Revenues:
Total revenues	11,107	14,052	39,544	34,035
Cost of revenues:
Total cost of revenues	7,975	13,511	32,341	34,794
Investments
Cost of revenues:
Total cost of revenues	$ 58	$ 50	$ 221	$ 176